Newsfeeds Archive - Spark Newswire

3 minute read

Analyst Ratings

Demystifying Collegium Pharmaceutical: Insights From 4 Analyst Reviews

May 10, 10:01 AM

Throughout the last three months, 4 analysts have evaluated Collegium Pharmaceutical (NASDAQ:COLL), offering a diverse set of opinions…

COLL

1 minute read

Collegium Announces Authorized Generic Agreement With Hikma Pharmaceuticals USA Inc. For Nucynta And Nucynta ER

By Benzinga Newsdesk

April 29, 8:22 AM

Collegium Pharmaceutical, Inc. (NASDAQ:COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced it has entered into

COLL

3 minute read

Analyst Ratings

Critical Insights From Collegium Pharmaceutical Analyst Ratings: What You Need To Know

By Benzinga Insights

April 11, 9:00 AM

4 analysts have shared their evaluations of Collegium Pharmaceutical (NASDAQ:COLL) during the recent three months, expressing a mix…

COLL

4 minute read

Analyst Ratings

Analyst Expectations For Collegium Pharmaceutical’s Future

By Benzinga Insights

February 2, 9:00 AM

During the last three months, 4 analysts shared their evaluations of Collegium Pharmaceutical (NASDAQ:COLL), revealing diverse outlooks from…

COLL

1 minute read

Why Collegium Pharmaceutical Shares Are Gaining Today

By Akanksha Bakshi

January 3, 12:39 PM

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) today announced FY24 financial

COLL

2 minute read

TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday

By Avi Kapoor

January 3, 11:24 AM

U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during Wednesday’s session after it disclosed receiving a preliminary non-binding acquisition offer.

ARWR